Company
About InCarda
Our Team
Board of Directors
Investors
Scientific and Medical Advisors
Careers
Our Pipeline
Pipeline Overview
InRhythm™ – Inhaled Antiarrhythmic for PAF
About Atrial Fibrillation
News
Contact
Company
About InCarda
Our Team
Board of Directors
Investors
Scientific and Medical Advisors
Careers
Our Pipeline
Pipeline Overview
InRhythm™ – Inhaled Antiarrhythmic for PAF
About Atrial Fibrillation
News
Contact
News & Updates
Filter By:
All
News
Press Releases
Events
Videos
Publications
Events
|
News
Grace Colón Participates in virtual workshop “Innovation in Drug Research and Development for Prevalent Chronic Diseases”
Read More
News
InCarda Therapeutics featured in Men’s Health
Read More
News
|
Press Releases
InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation
Read More
Events
|
News
InCarda’s CEO Grace Colon participated in a panel discussion at Biotech Showcase 2021 on January 11, 2021
Read More
News
Grace Colón Joins the First Rounders Podcast
Read More
Events
|
News
Grace Colón & Jeff Ho Join FIRESIDE chat with Umer Raffat & Michael DiFiore
Read More
Events
|
News
InCarda Therapeutics to Present Preliminary Phase 2 Data at American Heart Association 2020 Scientific Sessions (Nov. 13-17, 2020)
Read More
Press Releases
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
Read More
News
InCarda Therapeutics featured in Endpoints News
Read More
Press Releases
InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing
Read More
News
InCarda Therapeutics featured in FierceBiotech News
Read More
Events
|
News
Grace Colón Joins Panel Discussion Regarding Diversity and Inclusion During BIO Investor Forum Digital 2020
Read More
We’re proud to share what’s new.
Sign up to be the first to learn about new developments.
Name
*
:
Email
*
:
Company
*
:
We respect your
email privacy
Tweets by InCardaThera
Clinical Announcement
InCarda Therapeutics Recruiting for Phase 2 Clinical Trial in PAF
Read More